Table of Content

Executive Summary
Scope of Study

1. Global Adrenocortical Carcinoma Market Overview
1.1 Industry Outlook
1.1.1 Market Overview and Ecosystem
1.1.2 Market Trends
1.1.3 Epidemiological Analysis of Adrenocortical Carcinoma
1.1.3.1 By Region
1.1.4 Clinical Trials
1.1.4.1 By Phase
1.1.4.2 By Sponsor Type
1.1.5 Regulatory Landscape / Compliance
1.1.5.1 Legal Requirement and Framework in the U.S.
1.1.5.2 Legal Requirement and Framework in the E.U.
1.1.5.3 Legal Requirement and Framework in Asia-Pacific
1.2 Market Dynamics
1.2.1 Impact Analysis
1.2.2 Market Drivers
1.2.3 Market Restraints
1.2.4 Market Opportunities

2. Global Adrenocortical Carcinoma Market, By Region, $Million, 2023-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Size and Forecast
2.1.2.1 North America Adrenocortical Carcinoma Market (by Country)
2.1.2.1.1 U.S.
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Size and Forecast
2.2.2.1 Europe Adrenocortical Carcinoma Market (by Country)
2.2.2.1.1 U.K.
2.2.2.1.2 Germany
2.2.2.1.3 France
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Size and Forecast
2.3.2.1 Asia-Pacific Adrenocortical Carcinoma Market (by Country)
2.3.2.1.1 Japan

3. Global Adrenocortical Carcinoma Market - Competitive Benchmarking and Company Profiles
3.1 Competitive Landscape
3.1.1 Key Strategies and Developments by Company
3.1.1.1 Funding Activities
3.1.1.2 Mergers and Acquisitions
3.1.1.3 Regulatory Approvals
3.1.1.4 Partnerships, Collaborations, and Business Expansions
3.1.2 Key Developments Analysis
3.2 Company Profiles
3.2.1 HRA Pharma
3.2.1.1 Company Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers/End Users
3.2.1.4 Analyst View
3.2.2 Cytovation
3.2.2.1 Company Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers/End Users
3.2.2.4 Analyst View
3.2.3 Exelixis, Inc.
3.2.3.1 Company Overview
3.2.3.2 Product Portfolio
3.2.3.3 Target Customers/End Users
3.2.3.4 Analyst View
3.2.4 Bristol-Myers Squibb
3.2.4.1 Company Overview
3.2.4.2 Product Portfolio
3.2.4.3 Target Customers/End Users
3.2.4.4 Analyst View

4. Research Methodology

List of Figures
Figure Global Adrenocortical Carcinoma Market, Market Overview
Figure Global Adrenocortical Carcinoma Market, Epidemiological Analysis, U.S.
Figure Global Adrenocortical Carcinoma Market Coverage
Figure Global Adrenocortical Carcinoma Market Key Trends, Impact Analysis, 2023-2035
Figure Global Adrenocortical Carcinoma Market, Competitive Landscape, January 2022-April 2025

List of Tables
Table Global Adrenocortical Carcinoma Market, Regulatory Scenario
Table Global Adrenocortical Carcinoma Market Dynamics, Impact Analysis